TY - JOUR KW - buprenorphine KW - Family Medicine KW - Health Services Accessibility KW - Health Workforce KW - opioid-related disorders KW - Primary Health Care KW - Residency KW - Surveys and Questionnaires AU - V. Boggiano AU - Gilmore Wilson AU - E. B. Fagan AU - J. Kirk AU - K. Bossenbroek-Fedoriw AU - C. R. Tak A1 - AD - From the Department of Family Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill (VB, CGW, EBF, KBF); UNC Health Sciences at MAHEC, Asheville, NC (CGW, EBF, CRT); Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill (CGW); Department of Family and Community Medicine, Wake Forest School of Medicine, Winston-Salem, NC (JK); Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC (CRT).; From the Department of Family Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill (VB, CGW, EBF, KBF); UNC Health Sciences at MAHEC, Asheville, NC (CGW, EBF, CRT); Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill (CGW); Department of Family and Community Medicine, Wake Forest School of Medicine, Winston-Salem, NC (JK); Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC (CRT) courtenay.wilson@mahec.net.; From the Department of Family Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill (VB, CGW, EBF, KBF); UNC Health Sciences at MAHEC, Asheville, NC (CGW, EBF, CRT); Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill (CGW); Department of Family and Community Medicine, Wake Forest School of Medicine, Winston-Salem, NC (JK); Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC (CRT).; From the Department of Family Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill (VB, CGW, EBF, KB(TRUNCATED) BT - Journal of the American Board of Family Medicine : JABFM C5 - Education & Workforce; Healthcare Policy; Opioids & Substance Use CP - 6 CY - United States DO - 10.3122/jabfm.2020.06.200127 IS - 6 JF - Journal of the American Board of Family Medicine : JABFM LA - eng M1 - Journal Article PB - by the American Board of Family Medicine PP - United States PY - 2020 SN - 1558-7118; 1557-2625 SP - 998 EP - 1003 EP - T1 - The Impact on Future Prescribing Patterns of Opioid Use Disorder (OUD) Education and Waiver Provision During Residency T2 - Journal of the American Board of Family Medicine : JABFM TI - The Impact on Future Prescribing Patterns of Opioid Use Disorder (OUD) Education and Waiver Provision During Residency U1 - Education & Workforce; Healthcare Policy; Opioids & Substance Use U2 - 33219079 U3 - 10.3122/jabfm.2020.06.200127 VL - 33 VO - 1558-7118; 1557-2625 Y1 - 2020 Y2 - Nov-Dec ER -